MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death

Cardiovascular Research

Volumn 106, Issue 3, 2015, Pages 387-397

  Tang, Yaoping ^a,b   Wang, Yongchao ^a   Park, Kyoung Mi ^a   Hu, Qiuping ^a   Teoh, Jian Peng ^a   Broskova, Zuzana ^a   Ranganathan, Punithavathi ^a   Jayakumar, Calpurnia ^a   Li, Jie ^a   Su, Huabo ^a   Tang, Yaoliang ^a   Ramesh, Ganesan ^a   Kim, Il Man ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Apoptotic genes; Biased G protein coupled receptor signalling; Cardioprotection; arrestin

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA ARRESTIN; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; G PROTEIN COUPLED RECEPTOR; MICRORNA; MICRORNA 150; UNCLASSIFIED DRUG; EARLY GROWTH RESPONSE FACTOR 2; EGR2 PROTEIN, MOUSE; MIRN150 MICRORNA, MOUSE; MIRN150 MICRORNA, RAT; P2RX7 PROTEIN, MOUSE; PURINERGIC P2X7 RECEPTOR;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATRIAL FIBRILLATION; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; HEART FAILURE; HEART FUNCTION; HEART INJURY; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HISTOPATHOLOGY; IN VITRO STUDY; ISCHEMIC CARDIOMYOPATHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; ANIMAL; APOPTOSIS; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL SURVIVAL; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; KNOCKOUT MOUSE; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NEWBORN; PATHOLOGY; PREVENTION AND CONTROL; RNA INTERFERENCE; SPRAGUE DAWLEY RAT; TIME FACTOR;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EARLY GROWTH RESPONSE PROTEIN 2; GENE EXPRESSION REGULATION; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X7; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84930331083     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvv121     Document Type: Article

References (59)

1. van Rooij E, Marshall WS, Olson EN. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ Res 2008;103:919-928.
2. Catalucci D, Gallo P, Condorelli G. Micrornas in cardiovascular biology and heart disease. Circ Cardiovasc Genet 2009;2:402-408.
3. van Rooij E. The art of microRNA research. Circ Res 2011;108:219-234.
4. Devaux Y, Vausort M, McCann GP, Zangrando J, Kelly D, Razvi N, Zhang L, Ng LL, Wagner DR, Squire IB. MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarction. Circ Cardiovasc Genet 2013;6:290-298.
5. Liu Z, Zhou C, Liu Y,Wang S, Ye P, Miao X, Xia J. The expression levels of plasma micro-RNAs in atrial fibrillation patients. PLoS One 2012;7:e44906.
6. Topkara VK, Mann DL. Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc Drugs Ther 2011;25:171-182.
7. Duan Y, Zhou B, Su H, Liu Y, Du C. miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300. Exp Cell Res 2013; 319:173-184.
8. Martinelli NC, Cohen CR, Santos KG, Castro MA, Biolo A, Frick L, Silvello D, Lopes A, Schneider S, Andrades ME, Clausell N, Matte U, Rohde LE. An analysis of the global expression of microRNAs in an experimental model of physiological left ventricular hypertrophy. PLoS One 2014;9:e93271.
9. Ellis KL, Cameron VA, TroughtonRW, Frampton CM, Ellmers LJ, Richards AM. Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients. Eur J Heart Fail 2013;15:1138-1147.
10. Devaux Y, Vausort M, McCann GP, Kelly D, Collignon O, Ng LL,Wagner DR, Squire IB. A panel of 4 microRNAs facilitates the prediction of left ventricular contractility after acute myocardial infarction. PLoS One 2013;8:e70644.
11. WuQ, Jin H, Yang Z, Luo G, Lu Y, Li K, Ren G, Su T, Pan Y, Feng B, Xue Z,Wang X, Fan D. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun 2010;392:340-345.
12. Zhou L, Qi X, Potashkin JA, Abdul-Karim FW, Gorodeski GI. MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3-untranslated region of the gene that decrease steady-state levels of the transcript. J Biol Chem 2008;283:28274-28286.
13. Weng T, Mishra A, Guo Y,Wang Y, Su L, Huang C, Zhao C, Xiao X, Liu L. Regulation of lung surfactant secretion by microRNA-150. Biochem Biophys Res Commun 2012;422: 586-589.
14. Ashton KJ, Tupicoff A, Williams-Pritchard G, Kiessling CJ, See Hoe LE, Headrick JP, Peart JN. Unique transcriptional profile of sustained ligand-activated preconditioning in pre-and post-ischemic myocardium. PLoS One 2013;8:e72278.
15. Gidlof O, Smith JG, Melander O, LovkvistH, Hedblad B, Engstrom G, Nilsson P, Carlson J, BerglundG, Olsson S, Jood K, Jern C, Norrving B, Lindgren A, Erlinge D. Acommon missense variant in theATP receptor P2X7 is associated with reduced risk of cardiovascular events. PLoS One 2012;7:e37491.
16. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC,Wang J, Rajewsky N, Bender TP, Rajewsky K. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007;131:146-159.
17. Chen L,Wang Y, Pan Y, Zhang L, Shen C, Qin G, Ashraf M,Weintraub N, Ma G, Tang Y. Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochem Biophys Res Commun 2013;431:566-571.
18. Su H, Li J, Menon S, Liu J, Kumarapeli AR,Wei N,Wang X. Perturbation of cullin deneddylation via conditional Csn8 ablation impairs the ubiquitin-proteasome system and causes cardiomyocyte necrosis and dilated cardiomyopathy in mice. Circ Res 2011; 108:40-50.
19. Gold JI,GaoE, Shang X, PremontRT, Koch WJ. Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication. Circ Res 2012;111:1048-1053.
20. Ahmed RP, Haider HK, Buccini S, Li L, Jiang S, AshrafM. Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart. Circ Res 2011;109:60-70.
21. Dai B, Huang W, Xu M, Millard RW, Gao MH, Hammond HK, Menick DR, Ashraf M, Wang Y. Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function. J Am Coll Cardiol 2011;58:2118-2127.
22. Buccini S, Haider KH, Ahmed RP, Jiang S, Ashraf M. Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart. Basic Res Cardiol 2012;107:301.
23. Ramakrishna S, Kim IM, Petrovic V, Malin D, Wang IC, Kalin TV, Meliton L, Zhao YY, Ackerson T, Qin Y, Malik AB, Costa RH, Kalinichenko VV. Myocardium defects and ventricular hypoplasia in mice homozygous null for the Forkhead Box M1 transcription factor. Dev Dyn 2007;236:1000-1013.
24. Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV, Major ML, Gusarova GA, Yoder HM, Costa RH, Kalinichenko VV. The Forkhead Box M1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 2006;66:2153-2161.
25. Chatterjee TK, Basford JE, Knoll E, Tong WS, Blanco V, Blomkalns AL, Rudich S, Lentsch AB, Hui DY, Weintraub NL. HDAC9 knockout mice are protected from adipose tissue dysfunction and systemic metabolic disease during high fat feeding. Diabetes 2014;63:176-187.
26. Blomkalns AL, Gavrila D, Thomas M, Neltner BS, Blanco VM, Benjamin SB, McCormick ML, Stoll LL, Denning GM, Collins SP, Qin Z, Daugherty A, Cassis LA, Thompson RW, Weiss RM, Lindower PD, Pinney SM, Chatterjee T, Weintraub NL. CD14 directs adventitial macrophage precursor recruitment: role in early abdominal aortic aneurysm formation. J Am Heart Assoc 2013;2:e000065.
27. Zhang L, Zhou M,Wang Y, HuangW, Qin G,Weintraub NL, Tang Y. miR-92a inhibits vascular smooth muscle cell apoptosis: role of the MKK4-JNK pathway. Apoptosis 2014;19:975-983.
28. Su H, Li F, Ranek MJ,WeiN,Wang X.COP9signalosome regulates autophagosome maturation. Circulation 2011;124:2117-2128.
29. Kim IM, Tilley DG, Chen J, Salazar NC, Whalen EJ, Violin JD, Rockman HA. Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation. Proc Natl Acad Sci USA 2008;105:14555-14560.
30. Aurora AB, Mahmoud AI, Luo X, Johnson BA, van Rooij E, Matsuzaki S, Humphries KM, Hill JA, Bassel-Duby R, Sadek HA, Olson EN. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+) overload and cell death. J Clin Invest 2012; 122:1222-1232.
31. Yan X, Shichita T, Katsumata Y, Matsuhashi T, Ito H, Ito K, Anzai A, Endo J, Tamura Y, Kimura K, Fujita J, Shinmura K, Shen W, Yoshimura A, Fukuda K, Sano M. Deleterious effect of the IL-23/IL-17A axis and gdT cells on left ventricular remodeling after myocardial infarction. J Am Heart Assoc 2012;1:e004408.
32. Zidar N, Bostjancic E, Glavac D, Stajer D. MicroRNAs, innate immunity and ventricular rupture in human myocardial infarction. Dis Markers 2011;31:259-265.
33. Muthusamy S, DeMartino AM,Watson LJ, Brittian KR, Zafir A, Dassanayaka S, Hong KU, Jones SP. MicroRNA-539 is up-regulated in failing heart, and suppresses O-GlcNAcase expression. J Biol Chem 2014;289:29665-29676.
34. Wang X. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 2008;14:1012-1017.
35. Krek A, Grun D, Poy MN,Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. Combinatorial microRNA target predictions. Nat Genet 2005;37:495-500.
36. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003;115:787-798.
37. Werner T. Bioinformatics applications for pathway analysis of microarray data. Curr Opin Biotechnol 2008;19:50-54.
38. Haudek SB, Taffet GE, Schneider MD, Mann DL. TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J Clin Invest 2007;117:2692-2701.
39. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996;79:949-956.
40. Shukla PC, Singh KK, Quan A, Al-Omran M, Teoh H, Lovren F, Cao L, Rovira II, Pan Y, Brezden-Masley C, Yanagawa B, Gupta A, Deng CX, Coles JG, Leong-Poi H, StanfordWL,ParkerTG, SchneiderMD, FinkelT,VermaS.BRCA1is anessential regulator of heart function and survival following myocardial infarction. Nat Commun 2011;2:593.
41. Khand A,Gemmel I, Clark AL, Cleland JG. Is the prognosis of heart failure improving? J Am Coll Cardiol 2000;36:2284-2286.
42. Barth K, Pfleger C, Linge A, Sim JA, Surprenant A, Steinbronn N, Strasser RH, KasperM. Increased P2X7R expression in atrial cardiomyocytes of caveolin-1 deficient mice. Histochem Cell Biol 2010;134:31-38.
43. LaFramboise WA, Bombach KL, Dhir RJ, Muha N, Cullen RF, Pogozelski AR, Turk D, George JD, Guthrie RD, Magovern JA. Molecular dynamics of the compensatory response to myocardial infarct. J Mol Cell Cardiol 2005;38:103-117.
44. DuD, Jiang M, Liu M,Wang J, Xia C, Guan R, Shen L, Ji Y, Zhu D. Microglial P2X7 receptor in the hypothalamic paraventricular nuclei contributes to sympathoexcitatory responses in acute myocardial infarction rat. Neurosci Lett 2015;587:22-28.
45. Kim IM,Wang Y, Park KM, TangY, Teoh JP, Vinson J, Traynham CJ, Pironti G, Mao L, Su H, Johnson JA, Koch WJ, Rockman HA. b-arrestin1-biased b1-adrenergic receptor signaling regulates microRNA processing. Circ Res 2014;114:833-844.
46. Eulalio A, Mano M, Dal FerroM, Zentilin L, Sinagra G, Zacchigna S, Giacca M. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 2012;492:376-381.
47. Wang X, Ha T, Zou J, Ren D, Liu L, Zhang X, Kalbfleisch J, Gao X, Williams D, Li C. MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6. Cardiovasc Res 2014;102:385-395.
48. XuC,HuY,HouL, Ju J, Li X,DuN, Guan X, Liu Z, ZhangT, QinW, Shen N, Bilal MU, LuY, Zhang Y, Shan H. b-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression. J Mol Cell Cardiol 2014; 75:111-121.
49. ZhuJN, Chen R, Fu YH, LinQX,Huang S,GuoLL, Zhang MZ,DengCY,ZouX, Zhong SL, Yang M, Zhuang J, Yu XY, Shan ZX. Smad3 inactivation and MiR-29b upregulation mediate the effect of carvedilol on attenuating the acute myocardium infarction-induced myocardial fibrosis in rat. PLoS One 2013;8:e75557.
50. Matkovich SJ, Wang W, Tu Y, Eschenbacher WH, Dorn LE, Condorelli G, Diwan A, Nerbonne JM, Dorn GW II. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarizationwithout affecting hypertrophy in pressure-overloaded adult hearts. Circ Res 2010;106:166-175.
51. Castaldi A, ZagliaT,DiMauroV,CarulloP, ViggianiG,BorileG,Di Stefano B, SchiattarellaGG, Gualazzi MG, Elia L, Stirparo GG, Colorito ML, Pironti G, Kunderfranco P, Esposito G, Bang ML, Mongillo M, Condorelli G, Catalucci D. MicroRNA-133 modulates the b1-adrenergic receptor transduction cascade. Circ Res 2014;115:273-283.
52. Zhang Y, Huang XR,Wei LH, ChungAC, Yu CM, LanHY. miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-b/Smad3 signaling. Mol Ther 2014;22:974-985.
53. Noma T, Lemaire A, Naga Prasad SV, Barki-Harrington L, Tilley DG, Chen J, Le Corvoisier P, Violin JD, Wei H, Lefkowitz RJ, Rockman HA. Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest 2007;117:2445-2458.
54. Aldi S, Marino A, Tomita K, Corti F, Anand R, Olson KE, Marcus AJ, Levi R. E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role. FASEB J 2014;29:61-69.
55. Vergani A, Tezza S, D'Addio F, Fotino C, Liu K, Niewczas M, Bassi R, Molano RD, Kleffel S, Petrelli A, Soleti A, Ammirati E, Frigerio M, Visner G, Grassi F, Ferrero ME, Corradi D, Abdi R, Ricordi C, Sayegh MH, Pileggi A, Fiorina P. Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7. Circulation 2013;127:463-475.
56. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA 2007;104:7080-7085.
57. Arulkumaran N, Unwin RJ, Tam FW. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs 2011;20:897-915.
58. Liu Z, Ye P,Wang S, Wu J, Sun Y, Zhang A, Ren L, Cheng C, Huang X,Wang K, Deng P, Wu C, Yue Z, Xia J. MicroRNA-150 protects the heart from injury by inhibiting monocyte accumulation in a mouse model of acute myocardial infarction. Circ Cardiovasc Genet 2015;8:11-20.
59. Li X, Kong M, Jiang D, Qian J, Duan Q, Dong A. MicroRNA-150 aggravatesH2O2-induced cardiac myocyte injury by down-regulating c-myb gene. Acta Biochim Biophys Sin (Shanghai) 2013;45:734-741.